BCR and chronic myelogenous leukemia, BCR-ABL1 positive: We also analyzed the BCR to identify CML‐specific epitopes, and again found no differences in the diversity of IgM and IgG BCRs between TFR cases and relapsed cases (Figure S3A,B).